BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Feb 24, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-02-23

Reporting Person: LAPALME PIERRE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-23	Common Stock	M	100	$8.47	Acquired	18850	Direct
2011-02-23	Common Stock	S	100	$26.00	Disposed	18750	Direct
2011-02-24	Common Stock	M	15000	$5.92	Acquired	33750	Direct
2011-02-24	Common Stock	S	15000	$24.9397	Disposed	18750	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-23	Stock Option (right to buy)	$8.47	M	100	Disposed	2014-01-26	Common Stock (100)	Direct
2011-02-24	Stock Option (right to buy)	$5.92	M	15000	Disposed	2015-01-26	Common Stock (15000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500	Indirect

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received range from $24.91 to $25.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vested 1/4 each on April 27, 2004, July 27, 2004, October 27, 2004, and January 27, 2005.

F3: Original option grant vested 1/4 each on April 27, 2005, July 27, 2005, October 27, 2005, and January 27, 2006.